Učitavanje...
Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy
BACKGROUND: Patients with immunodeficiency diseases require lifelong treatment with immunoglobulin (Ig), yet few studies have vetted dosing strategies and effectiveness of Ig in older patient populations. Patients requiring subcutaneous (SC) Ig (SCIG) typically start with intravenous dosing before t...
Spremljeno u:
| Izdano u: | Allergy Asthma Clin Immunol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4273447/ https://ncbi.nlm.nih.gov/pubmed/25535489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-014-0063-8 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|